Patented Static Seizure Treatment Is Obvious, Petitioner Tells Board
ALEXANDRIA, Va. — A patent owner maintains in a March 26 petition for inter partes review (IPR) that it was the first to disclose, via inherency, a daily dose of ganaxolone...To view the full article, register now.
Already a subscriber? Click here to view full article